Central Gum And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 21-05-2024
- Paid Up Capital ₹ 2.50 M
as on 21-05-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.78 Cr
as on 21-05-2024
- Revenue -14.52%
(FY 2020)
- Profit 99.74%
(FY 2020)
- Ebitda 82.11%
(FY 2020)
- Net Worth -0.02%
(FY 2020)
- Total Assets 0.01%
(FY 2020)
About Central Gum And Chemicals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹1.78 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajesh Nayyar, Ajay Rawat, and Kamal Chopra serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PTC064513
- Company No.
064513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Central Gum And Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Nayyar  | Director | 12-Dec-2019 | Current |
| Ajay Rawat | Director | 16-Aug-2019 | Current |
| Kamal Chopra | Director | 01-Sep-2011 | Current |
Financial Performance of Central Gum And Chemicals.
Central Gum And Chemicals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.52% decrease. The company also saw a substantial improvement in profitability, with a 99.74% increase in profit. The company's net worth dipped by a decrease of 0.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Central Gum And Chemicals?
In 2017, Central Gum And Chemicals had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gsas Enterprises Private LimitedActive 17 years 2 monthsRajesh Nayyar and Kamal Chopra are mutual person
- Stahl Tecniks Private LimitedActive 40 years 6 months
Rajesh Nayyar and Kamal Chopra are mutual person
- Aarjay Integrated Services Private LimitedActive 29 years 6 months
Rajesh Nayyar and Ajay Rawat are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 16 Jan 2010 | ₹1.78 Cr | Satisfied |
How Many Employees Work at Central Gum And Chemicals?
Unlock and access historical data on people associated with Central Gum And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Central Gum And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Central Gum And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
